We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





COVID-19 Patients Recover Faster with Metabolic Activator Treatment, Study Shows

By HospiMedica International staff writers
Posted on 29 Jun 2021
Print article
Illustration
Illustration
Metabolic activators can reduce recovery time by as many as 3.5 days in patients with mild-to-moderate COVID-19, according to a new study.

Researchers from the Science for Life Laboratory (SciLifeLab) at KTH Royal Institute of Technology (Stockholm, Sweden) also found that treatment with the metabolic activators improved liver health and decreased the levels of inflammation, as shown by inflammatory markers. Their human phase 3 clinical study showed that patients with mild-to-moderate COVID-19 - who were also receiving standard care - experienced a 3.5 day reduction in recovery time when receiving the combination of metabolic activators, nicotinamide riboside (NR), L-serine, N-acetyl-L-cysteine (NAC), and L-carnitine tartrate. All four activators are aimed at improving mitochondrial function. The results of the study build on findings from phase 2 clinical data.

Through a randomized, placebo controlled, double blind phase three clinical trial, 309 outpatients were randomly assigned on a 3:1 basis to receive the metabolic activators or placebo. Patients received the combined activators or placebo twice a day for 14 days and clinical status was evaluated through daily telephone check-ins.

“Our phase 3 data shows that metabolic activators significantly improve the recovery, liver health, and markers of inflammation of patients with COVID-19,” said the study’s lead author, Adil Mardinoglu, professor at KTH and Kings College and research fellow at SciLifeLab. “Dysfunctional mitochondria have been implicated in worsened progression for COVID-19, and we are pleased to find that the combination of these metabolic activators helps to remedy the stress put on the body of an infected patient.”

Related Links:
KTH Royal Institute of Technology


Print article

Channels

Business

view channel
Illustration

44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event

The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.